The aim of this study was to experimentally assess the dosimetric impact of leaf interdigitation using different inverse treatment strategies for representative tumour sites and to identify the situations in which leaf interdigitation can benefit these tumour sites.
Material and methods
Sixty previously treated patients (15 nasopharyngeal carcinoma (NPC), 15 multiple brain metastasis (MBM), 15 cervical cancer and 15 prostate cancer) were re-planned for volumetric modulated arc therapy (VMAT), sliding window IMRT (dMLC) and step-and-shoot IMRT (ssIMRT) with and without leaf interdigitation. Various dosimetric variables, such as PTV coverage, OARs sparing, delivery efficiency and planning time, were evaluated for each plan. In addition, a protocol developed by our group was applied to identify the situations in which leaf interdigitation can achieve benefits in clinical practice.
Results
Leaf interdigitation produced few benefits in PTV homogeneity for the MBM VMAT plans and NPC ssIMRT plans. For OARs, sparing was equivalent with and without leaf interdigitation. Leaf interdigitation showed an increase in MUs for dMLC plans and a decrease in MUs for ssIMRT plans. Leaf interdigitation resulted in an increase in segments for dMLC plans and a decrease in segments for NPC and MBM ssIMRT plans. For beam on time, leaf interdigitation showed an increase in MBM dMLC, NPC ssIMRT and prostate ssIMRT plans. In addition, leaf interdigitation saved planning time for VMAT and dMLC plans but increased planning time for ssIMRT plans.
Conclusion
Leaf interdigitation does not improve plan quality when performing inverse treatment strategies, regardless of whether the target is simple or complex. However, it influences the delivery efficiency and planning time. Based on these observations, our study suggests that leaf interdigitation should be utilized when performing MBM VMAT plans and NPC ssIMRT plans.
The online version of this article (doi:10.1186/s13014-016-0655-1) contains supplementary material, which is available to authorized users.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JD and YY are responsible for the conception and design of the study. JD collected the data and contributed to the cases. JD and XM created the manuscript draft. JD and XM performed the data analysis. TL generated the plans for the various techniques. All authors reviewed and approved the final manuscript.
Abkürzungen
3D
Three dimensional
CI
conformity index
CRT
conformal radiation therapy
CT
computed tomography
CTV
clinical target volume
dMLC
sliding window IMRT
DVH
dose volume histogram
HI
homogeneity index
IMRT
intensity modulated radiotherapy
MBM
multiple brain metastasis
MLC
multileaf collimator
MU
monitor units
NPC
nasopharyngeal carcinoma
OARs
organs at risk
PTV
planning target volume
SIB
simultaneous integrated boost
ssIMRT
step-and-shoot IMRT
TPS
treatment planning system
VMAT
volumetric modulated arc therapy
Background
Multileaf collimators (MLCs) are modulation devices that are a key invention in the history of radiation therapy [1]. MLCs enable irregular segments and serve as a shielding device that improves target dose conformity. The properties of MLCs, such as leaf width, movement velocity and tongue-and-groove design, influence the dosimetric quality and effectiveness in various IMRT strategies for different types of cancer. Several researchers previously published studies on the dosimetric effects of these features of MLCs. Leaf width is available in increasingly thinner widths on the open market. Several planning studies were performed to evaluate the dosimetric impact of MLC leaf width [2‐9]. Treatment plans using thinner leaf width MLCs can result in greater sparing of organs at risk (OARs). These plans have been delivered with more segments and monitor units. However, the clinical benefit is not unequivocal [6, 7]. Moreover, other phenomena were found in the published literature because the thinner leaf provided improved target coverage and dose gradients for small volumes [8, 9]. In addition, the smaller MLC leaf width was more effective for complex-shaped targets [8]. Different leaf velocities have larger impacts on dMLC plans. Hilke Vorwerk et al. [10] found that high leaf velocity showed the best protection for OARs although higher than 3.0 cm/sec leaf velocity is not mechanically applicable. They recommended an optimal leaf velocity of 2.5 cm/sec. The tongue-and-groove design is a feature of MLCs that reduces leakage between leaves. A published study demonstrated that the tongue-and-groove effect was clinically insignificant for multiple-field IMRT because of the smearing effects of individual fields [11]. To minimize the contribution of the tongue and groove effect in dual-arc VMAT plans, several scholars proposed two coplanar arcs with the collimator rotated to some degree [12‐14].
Figure 1 shows that as a property of MLCs, leaf interdigitation refers to the end of a trailing leaf extending past the end of an adjacent leading leaf. Namely, opposing leaves of adjacent rows can overlap [15, 16]. With interdigitation, MLC capabilities have caught up with the ability of the treatment planning system to create island fields in difficult cases. Theoretically, the complex geometry segments increase the degrees of freedom for generating high quality plans. From this perspective, interdigitation allows easy planning of IMRT techniques. However, leaf interdigitation has a limitation, in that it may cause a leaf collision and increase the wear of MLCs. In fact, several researchers with different views have published regarding this topic [4, 17‐19]. However, currently, experimental investigations of the ability of MLC leaf interdigitation with inverse planning techniques for different types of tumour sites are scarce, although interdigitation is widely applied in 3D-CRT techniques.
×
Anzeige
In this study, we further evaluated this topic and assessed the dosimetric advantages and effectiveness of leaf interdigitation with volumetric modulated arc therapy (VMAT), sliding window IMRT (dMLC) and step-and-shoot IMRT (ssIMRT) for four types of representative tumour sites. We expect to determine suitable conditions in which leaf interdigitation is superior to leaf non-interdigitation. Our research may provide useful guidelines for selecting reasonable treatment methods in clinical practice.
Material and methods
Patients
To experimentally evaluate the effect of MLC leaf interdigitation, computed tomography data sets from the four following tumour sites identified at our institution between 2014 and 2015 were randomly selected for this study: nasopharyngeal carcinoma with simultaneous integrated boosts (NPC-SIB) (15 patients), multiple brain metastasis (MBM) (15 patients, 3 to 6 isolate targets), cervical cancer (15 patients) and prostate cancer (15 patients). The four tumour sites represent four characteristic PTV shapes, rather complex target volume, multi-isolated target volume, horseshoe-shaped target volume and spherical (simple) target volume. The ethics committee of Shandong Cancer Hospital and Institute approved this study. In this study, the same dose prescription was used for each case to better investigate the effect of leaf interdigitation in different radiotherapy approaches. The PTV definition and dose constraints for the targets and OARs are summarized in Table 1.
Table 1
Target description, PTV prescription and OARs for tumor sites and OARs
Abbreviations: HR high risk lymphatic regions, LR low risk regions
Planning techniques and beam setup
A total of 360 plans were generated for the planning study, in which 6 plans were generated per patient using dual arc VMAT, dMLC and ssIMRT with or without leaf interdigitation. Elekta synergy linear accelerator was used in this study. The linac was equipped with the MLCi2 MLC, and the dose rate was 600 MU/min. The MLCi2 with the interdigitation feature has 40 pairs of leaves with a 10 mm width at the isocentre. All plans were generated by an expert planner using our clinical TPS (Monaco version 3.3, Elekta AB, Sweden). The experiments were conducted on an HP Z820 workstation with an Intel Xeon E5-2670 processor at 2.6 GHz with 32 GB RAM and 32 cores.
The expert planner manually designed 3 plans for each patient with the clinical TPS carrying leaf interdigitation permission as follows: dual arc VMAT, dMLC and ssIMRT with 7–9 equiangular beams. The OAR doses were restricted according to RTOG0225, ROG0615 and QUANTEC. In this study, we adopted Sharfo’s methods to avoid the consecutive generation of plans for a single patient [20]. We altered the objective function of DVH and priorities during optimization to achieve the best results for each leaf interdigitation plan. If plan quality levelled off and no significant further improvement was expected, we stopped altering the objective function of DVH and priorities on the plans, and there was no time limit. For acquiring the planning time, the leaf interdigitation plans were generated again using the last objective function of DVH and priorities without previous fluence or segmentation. When the first step was complete, leaf interdigitation permission was abandoned by modifying the TPS data. Then, for a fair comparison, leaf non-interdigitation plans (without) were generated on the condition that the planning parameters of the machine, such as the priorities and dosimetric objectives, were identical to those of the leaf interdigitation plans (with). The leaf non-interdigitation plans were generated without any interference of the fluence and segmentation of the leaf interdigitation plans. After calculation, to eliminate the dependence of the plans on tumour coverage, each plan was normalized such that the prescription dose covered at least 95 % of the PTV.
Anzeige
Plan evaluation criteria
PTV and main OARs metrics extracted from dose-volume histograms (DVHs) were evaluated. The PTV, maximum dose (dose received by 2 % of the target volume, D2%), minimum dose (dose received by 98 % of the target volume, D98%) and mean dose (Dmean) were analysed. For serial OARs, such as the spinal cord and brainstem, D2% and Dmean were analysed. For parallel organs, such as the rectum and bladder, Dmean was emphasized. To evaluate the overall quality of the treatment plans, the conformity index (CI) and homogeneity index (HI) were calculated as follows [21]:
Where TVRI is the target volume covered by the prescription isodose, TV is the target volume, and VRI is the volume of the prescription isodose. The CI ranges from 0 to 1, where 1 indicates perfect overlap (identical structures). A value near 0 indicates total absence of conformation, i.e., the target volume is not irradiated.
Where D2% is the dose received by 2 % of the target volume, D98% is the dose received by 98 % of the target volume, and Dprescription is the prescription dose of the target volume. The HI ranges from 0 to 1, where 0 is the ideal value. A higher HI indicates poorer homogeneity.
To evaluate dose delivery efficiency, monitor units (MUs), control points (or segments) per fraction and beam on time were compared. In addition, planning time for each plan was also considered in the evaluation of planning efficiency. In this study, we developed a protocol to define the indispensability of leaf interdigitation with different inverse planning technologies for four tumour sites. The protocol, on the basis of the ‘Traffic Light Protocol’, has three levels: level red, level yellow and level green. Superior quality plan is the primary consideration regardless of the delivery efficiency. Plan quality was assessed by an experienced radiation therapist. Delivery efficiency is another consideration if the plan quality is equivalent. We quantify delivery efficiency by assessing the scores of every index (MUs, segments, and beam on time). Regarding the leaf interdigitation plans, one point indicates high delivery efficiency. Zero point indicates equivalent delivery efficiency or low delivery efficiency. We evaluated the indispensability of leaf interdigitation by comparing the scores.
1)
Level red (with): Requires leaf interdigitation. Case 1: a superior quality plan was identified regardless of the delivery efficiency. Case 2: high delivery efficiency was found when the plan quality is equivalent.
2)
Level yellow (with/without): Leaf interdigitation is dispensable. The plan quality is equivalent, and the delivery efficiency are identical.
3)
Level green (without): No need for leaf interdigitation. Case 1: the plan quality is inferior regardless of the delivery efficiency. Case 2: low delivery efficiency was found when the plan quality is equivalent.
Statistical analysis
Paired Student’s t-tests or Wilcoxon rank tests were used to compare the differences between the leaf interdigitation plans and the leaf non-interdigitation plans. Paired Student's t-test was used when the data fit a normal distribution. If the data did not fit the normal distribution, we selected the Wilcoxon rank test instead of paired Student's t-test. All analyses were performed using SPSS version 16.0 (SPSS, Chicago, IL, USA). P < 0.05 was considered significant.
Results
PTV coverage
All generated plans were clinically acceptable. For the MBM patients, the comparison of leaf interdigitation plans and leaf non-interdigitation plans with respect to PTV is summarized in Table 2. Leaf interdigitation yielded equivalent results for the observed evaluation parameters in the dMLC and ssIMRT plans. For the NPC-SIB patients, leaf interdigitation provided little benefit with respect to the HI for the ssIMRT plans in spite of a large and complex target volume. In the other two cases, all evaluation variables of PTV were equivalent for leaf interdigitation plans and leaf non-interdigitation plans. The PTV comparative results of the NPC-SIB, cervical and prostate cases are summarized in the supplementary material (see Additional file 1: S1, S2 and S3).
Table 2
The PTV comparative results of leaf interdigitation plans and leaf non-interdigitation plans in MBM sites
VMAT
dMLC
ssIMRT
with-without
with-without
with-without
PTVmax(Gy)
64.9 ± 1.1/62.8 ± 0.9
65.5 ± 1.8/65.9 ± 1.5
64.7 ± 2.2/65.1 ± 2.8
PTVmin(Gy)
58.8 ± 1.5/58.5 ± 1.7*
57.9 ± 1.9/58.2 ± 1.8
57.6 ± 1.3/57.2 ± 1.5
PTVmean(Gy)
62.4 ± 0.5/62.3 ± 0.6
62.1 ± 0.9/62.6 ± 0.8
61.9 ± 1.1/62.8 ± 0.9
HI
0.09 ± 0.028/0.108 ± 0.04*
0.091 ± 0.042/0.101 ± 0.052
0.102 ± 0.091/0.102 ± 0.07
CI
0.79 ± 0.06/0.78 ± 0.05
0.75 ± 0.1/0.75 ± 0.12
0.74 ± 0.11/0.74 ± 0.15
Note: * represents statistically significant between the two sets of data
OARs doses
Table 3 shows all of the OARs parameters for the MBM patients. The OARs comparative results for the NPC-SIB, cervical and prostate cases are summarized in the supplementary data (see Additional file 1: S4, S5 and S6). No statistically significant differences were found in any of the leaf interdigitation and leaf non-interdigitation plans.
Table 3
The OARs parameter values of leaf interdigitation plans and leaf non-interdigitation plans in MBM sites
VMAT(Gy)
dMLC(Gy)
ssIMRT(Gy)
with-without
with-without
with-without
Brainstem
37.0 ± 14.8/37.2 ± 15.1
37.8 ± 13.2/38.1 ± 16.5
37.2 ± 14.8/37.9 ± 16.2
Optic nerves-L
13.8 ± 11.6/12.9 ± 9.4
13.4 ± 9.6/13.8 ± 9.9
14.3 ± 10.5/13.5 ± 9.8
Optic nerves-R
17.4 ± 8.8/11.3 ± 9.2
17.9 ± 9.8/12.5 ± 10.3
17.5 ± 7.9/16.4 ± 9.4
Eye -L
12.7 ± 11.3/12.6 ± 10.7
12.9 ± 10.3/12.8 ± 10.2
13.3 ± 10.1/13.2 ± 10.9
Eye-R
13.2 ± 11.8/13.3 ± 13.0
14.4 ± 10.7/15.1 ± 11.0
13.3 ± 9.8/13.6 ± 9.5
Lens-L
3.6 ± 1.7/3.5 ± 1.7
3.6 ± 1.8/3.5 ± 1.5
3.7 ± 1.6/3.6 ± 1.9
Lens-R
3.5 ± 1.9/3.5 ± 1.9
3.5 ± 1.8/3.6 ± 1.6
3.6 ± 1.2/3.6 ± 1.8
Note: For brainstem, optic nerves, lens and eyes, the value represents D2%
Delivery efficiency
The monitor units, segments, beam on time and planning time for each technique used in the MBM patients are shown in Table 4. We observed that leaf interdigitation generated more MUs, segments and beam on time in the dMLC plans. For the VMAT plans, leaf interdigitation showed an increase of 3.7 % compared with leaf non-interdigitation in the MUs. For the ssIMRT plans, leaf interdigitation showed decreases of 25.3 % and 19.6 % in the MUs and segments, respectively. The delivery efficiency results from the NPC-SIB, cervical and prostate cases are summarized in the supplementary data (see Additional file 1: S7, S8 and S9). All results revealed that leaf interdigitation increased the MUs and segments in the dMLC plans. However, leaf interdigitation reduced the MUs in the ssIMRT plans for NPC-SIB patients and MBM patients. We found significant differences in the segments and beam on time in the NPS-SIB patients. In addition, significant differences were also observed in the beam on time in the prostate patients. Notably, leaf interdigitation saved the planning time in the VMAT and dMLC plans. By contrast, the planning time in the leaf interdigitation protocols was increased in the ssIMRT plans.
Table 4
Delivery efficiency of leaf interdigitation plans and leaf non-interdigitation plans in MBM sites
VMAT
dMLC
ssIMRT
with-without
with-without
with-without
MUs
680 ± 54/656 ± 45*
917 ± 102/792 ± 128*
621 ± 94/831 ± 103*
Segments
169 ± 8/169 ± 8
575 ± 97/346 ± 91*
82 ± 11/102 ± 21*
BOT(s)
238 ± 19/237 ± 19
548 ± 72/460 ± 73*
545 ± 51/560 ± 54
PT(s)
17 ± 5/23 ± 4*
7 ± 2/12 ± 5*
15 ± 6/6 ± 5*
Note: BOT represents beam on time, PT represents planning time, * represents statistically significant between the two sets of data
Anzeige
Conditions in which leaf interdigitation provides benefits
On the basis of these observations and the abovementioned protocol, we defined the conditions in which leaf interdigitation provides benefits. These conditions are presented in Table 5.
Table 5
The conditions that leaf interdigitation can generate benefits
Tumour sites
VMAT
dMLC
ssIMRT
NPC
without
without
with
MBM
with
without
with/without
Cervical
without
without
with/without
Prostate
without
without
without
Note: with represents needs for leaf interdigitation; with/without represents needs are formidable evaluation for leaf interdigitation; without represents no needs for leaf interdigitation
Discussion
MLCs have significant efficacy and efficiency in radiotherapy. They are now widely applied and have become integral parts of every radiotherapy department. In 3D-CRT and IMRT technologies, MLCs play a critical role in generating conformal shaping and providing the intensity-modulated beam. The characteristics and dosimetry issues associated with MLCs are crucial for optimal treatment quality and treatment safety and efficiency.
In this report, we present an experimental study of leaf interdigitation with different inverse planning techniques for representative tumour sites. To keep the bias of the study low, one expert planner generated the leaf interdigitation and leaf non-interdigitation plans using the same TPS version, the same linear accelerator, the same planning parameters and the same dose algorithms. The aim of this research was to assess the dosimetric impact of leaf interdigitation on multiple inverse planning techniques for representative tumour sites. We expected to detect the conditions in which leaf interdigitation can provide benefits. The results indicated that leaf interdigitation could not improve plan quality in multiple inverse planning techniques, regardless of the complexity of the target. However, leaf interdigitation influenced delivery efficiency, particularly in the dMLC and ssIMRT plans. Furthermore, the planning time was shortened by leaf interdigitation in the VMAT and dMLC plans. It is interesting that this phenomenon did not exist in the ssIMRT plans. By contrast, leaf interdigitation increased the planning time for ssIMRT plans.
Our findings are consistent with that of the study by Kesteren et al. [17]. Their studied revealed that leaf interdigitation had a minimal dosimetric impact on prostate and rectal cancer treatment plans in VMAT treatments using the Pinnacle TPS. Lafond et al. [3] found no dosimetric advantages to using MLCi2 interdigitation for HNC in VMAT plans. Furthermore, their study showed that interdigitation could improve efficiency. In our study, we found that interdigitation increased the MUs for the MBM VMAT plans and all dMLC plans. However, this phenomenon was not found in other cases. Instead, interdigitation resulted in a decrease in MUs for all ssIMRT cases, except prostate cases. Moreover, consistent with the literature [22], we also observed that leaf interdigitation shortened the solution time for the VMAT plans.
Anzeige
This study reveals that leaf interdigitation can reduce VMAT and dMLC planning time. Inverse treatment plans must be repeatedly altered by cost functions, priorities and other planning parameters. The process is time-consuming, particularly in complex cases. In addition, with the growing popularity of VMAT and dMLC for radiation therapy, there is a greater need for improving the planning efficiency. Our results demonstrated that leaf interdigitation could increase the dosimetrist efficiency by saving planning time in the design of VMAT and dMLC treatment plans.
MLC leaf interdigitation can create island fields in complex situations, whereby one trailing leaf advances beyond the position of an adjacent leading leaf. For the CRT plans of multiple tumours, leaf interdigitation is commonly applied to obtain reasonable distributions. Leaf interdigitation is forbidden in inverse treatment plans in early types of MLCs with an Elekta linear accelerator. Then, the suppliers adopted the MLCi2 MLCs, which allowed interdigitation on inverse treatment plans. Theoretically, leaf interdigitation increases the degrees of freedom for better treatment plans. However, we did not obtain superior quality plans by leaf interdigitation in this study, except for small significant differences in a few cases. The process of inverse planning optimization entails searching for the local optimum in the solution space, although the global optimum is difficult to identify. In principle, non-interdigitation MLC treatment plan optimization solutions are a sub-set of interdigitation MLC plan optimization solutions. Because of the addition of more degrees of freedom, it is possible that leaf interdigitation obtains more paths to search for the local optimum than leaf non-interdigitation [17]. Thus, leaf interdigitation can save time in the search for the local optimum. This may explain the shortened planning time results observed in this study for the VMAT and dMLC plans. However, we found that the planning time was increased for the ssIMRT plans. Likely, there may be a balance between the search space and search path. The sliding window technique used for dMLC and VMAT may not suffer as large a discrepancy between search space and search path as the ssIMRT-sequencing algorithm when changing from non-interdigitation to interdigitation.
Utilizing the modulation of leaf movement, the number of fields, dose rate and other parameters, balance was reached between the target volume coverage and the OARs doses in inverse planning technologies. Leaf interdigitation is an intensity modulation method for inverse planning strategies. In this study, we did not acquire higher quality plans. It is possible that the local optimum in the solution space does not require leaf interdigitation because other intensity modulation methods can offset the lack of leaf interdigitation. However, leaf interdigitation may change the paths of the optimization solutions. Consequently, the MUs, segments and delivery time may effect changes. As an example, leaf interdigitation splits the segments and generates a greater number of smaller and narrower segments in dMLC plans [23]. Therefore, leaf interdigitation dMLC plans lead to more segments than leaf non-interdigitation dMLC plans. In addition, we conclude that the optimization algorithm in the Monaco TPS may influence the MUs and delivery time. This assumption should be confirmed in future studies.
Our study demonstrates that leaf interdigitation may not always generate benefits when performing inverse treatment strategies for various tumour sites. The study may provide useful guidelines for selecting reasonable planning treatment methods in current clinical practice. It should be noted that the results are related to one linac and one TPS. Different planning systems and different Linac produced by other manufacturers should be studied in future investigations to overcome the variance between treatment facilities.
Anzeige
Conclusion
In this report, the effect of MLC leaf interdigitation on inverse treatment plans was experimentally studied in multiple tumour sites. We demonstrate that leaf interdigitation leads to obvious differences in the delivery efficiency of dMLC plans and ssIMRT plans. Furthermore, leaf interdigitation may influence planning efficiency without affecting target coverage and OARs sparing. On the basis of these observations, our study suggests that leaf interdigitation should be utilized when performing MBM VMAT and NPC ssIMRT plans.
Acknowledgements
The authors would like to thank Zhu Jian, Gong Guanzhong, Jin jianxue and Lu Jie for their guidance.
Funding
This research was supported by the National Natural Science Fund of China (No. 81472811 and No. 81272699) and the Science and Technology Planning Project of Shandong Province (2014GSFll8011).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JD and YY are responsible for the conception and design of the study. JD collected the data and contributed to the cases. JD and XM created the manuscript draft. JD and XM performed the data analysis. TL generated the plans for the various techniques. All authors reviewed and approved the final manuscript.
Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.
Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.
Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.
Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.
Update Onkologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.